Matches in Wikidata for { <http://www.wikidata.org/entity/Q90281755> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q90281755 description "article scientifique publié en 2019" @default.
- Q90281755 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q90281755 description "scientific article published on 24 April 2019" @default.
- Q90281755 description "wetenschappelijk artikel" @default.
- Q90281755 description "наукова стаття, опублікована 24 квітня 2019" @default.
- Q90281755 name "Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial" @default.
- Q90281755 name "Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial" @default.
- Q90281755 type Item @default.
- Q90281755 label "Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial" @default.
- Q90281755 label "Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial" @default.
- Q90281755 prefLabel "Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial" @default.
- Q90281755 prefLabel "Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial" @default.
- Q90281755 P1433 Q90281755-62BE9D3E-1B3D-4D14-9061-9632B3F8ECAE @default.
- Q90281755 P1476 Q90281755-7053752A-F742-43C3-8859-CC9B1892C23E @default.
- Q90281755 P2093 Q90281755-2762FE46-2B59-4584-9B48-E62D867D1EA7 @default.
- Q90281755 P2093 Q90281755-30E1D4E7-00C2-4EA3-9419-3D42DB04B4EF @default.
- Q90281755 P2093 Q90281755-4FB0D553-9AD7-4D0D-8D4F-2CB7EFBE8FA9 @default.
- Q90281755 P2093 Q90281755-5890A426-9AC1-4E2A-8F6A-DF16D39E452F @default.
- Q90281755 P2093 Q90281755-B0E0C471-5E18-4FDE-AB99-896F7596A2F7 @default.
- Q90281755 P2093 Q90281755-B422D84E-FABB-45FB-85B7-2D47B2FB3F1D @default.
- Q90281755 P304 Q90281755-161EE3A4-33E8-4A65-B93B-D294DC7737B9 @default.
- Q90281755 P31 Q90281755-9056C90D-D468-4526-B7DB-74091217D88E @default.
- Q90281755 P356 Q90281755-49683B5F-7F02-4FFB-B474-7C79B6CAAB0D @default.
- Q90281755 P433 Q90281755-2754DC86-2FFD-425E-ABD3-A24966F1EDA6 @default.
- Q90281755 P478 Q90281755-459F48AB-B537-4749-A0C5-12648D83E12A @default.
- Q90281755 P50 Q90281755-23FFAB5F-4737-4FD7-A077-10E9A379A902 @default.
- Q90281755 P577 Q90281755-4AD823DD-21DE-40DA-8B9A-D457E7C67B15 @default.
- Q90281755 P698 Q90281755-E0A9F348-0A0B-4C1C-B4A1-74F1EE946A61 @default.
- Q90281755 P921 Q90281755-3DE9DFDB-F54F-4AB8-9EC0-47E05546CF6A @default.
- Q90281755 P921 Q90281755-95E614F6-2488-4D50-88CE-197F1A22D904 @default.
- Q90281755 P921 Q90281755-9CDC392E-BA24-400A-BB96-79389F52E1D7 @default.
- Q90281755 P921 Q90281755-A0DFAF41-BEA7-49B3-AA00-107A64DDF31E @default.
- Q90281755 P356 ANNRHEUMDIS-2019-215183 @default.
- Q90281755 P698 31018960 @default.
- Q90281755 P1433 Q4767876 @default.
- Q90281755 P1476 "Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial" @default.
- Q90281755 P2093 "Benjamin Hsu" @default.
- Q90281755 P2093 "Bidisha Dasgupta" @default.
- Q90281755 P2093 "Dick de Vries" @default.
- Q90281755 P2093 "Ian Gourley" @default.
- Q90281755 P2093 "Kristen Sweet" @default.
- Q90281755 P2093 "Matthew J Loza" @default.
- Q90281755 P304 "1439-1441" @default.
- Q90281755 P31 Q13442814 @default.
- Q90281755 P356 "10.1136/ANNRHEUMDIS-2019-215183" @default.
- Q90281755 P433 "10" @default.
- Q90281755 P478 "78" @default.
- Q90281755 P50 Q60325744 @default.
- Q90281755 P577 "2019-04-24T00:00:00Z" @default.
- Q90281755 P698 "31018960" @default.
- Q90281755 P921 Q187255 @default.
- Q90281755 P921 Q348260 @default.
- Q90281755 P921 Q3718630 @default.
- Q90281755 P921 Q42824827 @default.